FY2025 · period end Dec '25 · from the 10-K filed Feb 25, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $9.04B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001193125-26-248342 | May 29, 2026 | May 29, 2026 | May 29, 2026 20:15 UTC | EDGAR |
| 8-K | 0001524472-26-000091 | May 14, 2026 | May 18, 2026 | May 18, 2026 20:19 UTC | EDGAR |
| 8-K | 0001524472-26-000065 | Apr 28, 2026 | Apr 28, 2026 | Apr 28, 2026 11:03 UTC | EDGAR |
| 10-Q | 0001524472-26-000068 | Mar 31, 2026 | Apr 28, 2026 | Apr 28, 2026 16:48 UTC | EDGAR |
| 10-K | 0001524472-26-000012 | Dec 31, 2025 | Feb 25, 2026 | Feb 25, 2026 18:36 UTC | EDGAR |
| 8-K | 0001524472-26-000014 | Feb 25, 2026 | Feb 25, 2026 | Feb 25, 2026 21:20 UTC | EDGAR |
| 8-K | 0001524472-26-000008 | Feb 10, 2026 | Feb 10, 2026 | Feb 10, 2026 12:02 UTC | EDGAR |
| 8-K | 0001524472-25-000043 | Oct 28, 2025 | Oct 28, 2025 | Oct 28, 2025 11:03 UTC | EDGAR |
Direct links to SEC EDGAR. XYL has additional filings available on the SEC site.
6 numbers Xylem Inc. later changed — same XBRL tag, both filings linked.
Operating Income (Loss)·Q2 2017
Minor restatementwas$139M
Revised down in a 10-K.
Liabilities·As of Dec 31, 2014
Minor restatementwas$2.7B
Revised down in a 10-K.
Operating Income (Loss)·3 months to Dec 2017
Minor restatementwas$179M
Revised down in a 10-K.
Assets·As of Dec 31, 2013
Minor restatementwas$4.9B
Revised down in a 10-K.
Assets·As of Dec 31, 2014
Minor restatementwas$4.9B
Revised down in a 10-K.
Assets, Current·As of Dec 31, 2014
Minor restatementwas$2.1B
Revised down in a 10-K.
XYL is not the only one.
See every restatement we've found across the market — or get an alert the next time XYL revises a number.
Restatements are detected by comparing every vintage of a fact across all of Xylem Inc.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows XYL's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling Xylem Inc. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on XYL yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on XYL and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $7.36B |
| $5.52B |
| $5.20B |
| Gross Profit | $3.48B | $3.21B | $2.72B | $2.08B | $1.98B |
|---|
| Operating Income | $1.22B | $1.01B | $0.65B | $0.62B | $0.58B |
|---|
| Net Income | $0.96B | $0.89B | $0.61B | $0.35B | $0.43B |
|---|
| EPS (Diluted) | $3.92 | $3.65 | $2.79 | $1.96 | $2.35 |
|---|
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $17.63B | $16.49B | $16.11B | $7.95B | $8.28B |
| Total Liabilities | $5.88B | $5.61B | $5.94B | $4.45B | $5.05B |
| Stockholders' Equity | $11.49B | $10.65B | $10.18B | $3.50B | $3.23B |
| Cash & Equivalents | $1.48B | $1.12B | $1.02B | $0.94B | $1.35B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.24B | $1.26B | $0.84B | $0.60B | $0.54B |
| Capital Expenditures | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 38.5% | 37.5% | 36.9% | 37.7% | 38.0% |
| Operating Margin | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% |
| Net Margin | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% |
| Return on Equity | 8.6% | 8.5% | 8.9% | 10.6% | 13.8% |
| Return on Assets | 5.6% | 5.5% | 5.1% | 4.4% | 5.0% |
| Debt / Equity | 0.22× | 0.19× | 0.22× | 0.54× | 0.76× |
